John
  • Male
  • Las Vegas, NV
  • United States
Share on Facebook
Share on Facebook MySpace

John's Discussions

ASCO Conference Highlights: Metastatic Colorectal Cancer, Bladder Cancer

ASCO conference emerged out to be a breakthrough platform for several oncology abstracts including Colorectal Cancer, Metastatic Colorectal Cancer, and Bladder Cancer. Here are a few abstracts…Continue

Tags: beacon, encorafenib, favezelimab, label, results

Started Jul 7, 2022

ASCO Conference Abstracts - Major Data Readouts

Virtual ASCO conference schedule happened from May 29 to May 31 and was an…Continue

Started Jul 6, 2022

Gifts Received

Gift

John has not received any gifts yet

Give a Gift

 

John's Page

Latest Activity

John posted a discussion

ASCO Conference Highlights: Metastatic Colorectal Cancer, Bladder Cancer

ASCO conference emerged out to be a breakthrough platform for several oncology abstracts including Colorectal Cancer, Metastatic Colorectal Cancer, and Bladder Cancer. Here are a few abstracts covered from the field. Olympia Trial - PARP inhibitors demonstrated activity in multiple cancers which are related to BRCA mutations. AstraZeneca’s Lynparza (olaparib), one such PARP…See More
Jul 7, 2022
John posted discussions
Jul 6, 2022
John posted discussions
Jul 5, 2022
John posted a discussion

Trending & Popular Market Research Reports 2022 by DelveInsight

Obstructive Sleep Apnea MarketDelveInsight's Obstructive Sleep Apnea (OSA) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Obstructive Sleep Apnea (OSA), historical and forecasted epidemiology as well as the Obstructive Sleep Apnea (OSA) market trends in 7MM.…See More
Jun 30, 2022
John posted a discussion

Treatment resistant depression Market Insight, Epidemiology And Market Forecast 2032

Treatment-resistant Depression (TRD) typically refers to inadequate response to at least one antidepressant trial of adequate doses and duration. Treatment-resistant Depression is a relatively common occurrence in clinical practice, with up to 50–60% of the patients not achieving adequate response following antidepressant treatment.Related Topics…See More
Jun 29, 2022
John posted discussions
Jun 28, 2022
John posted discussions
Jun 24, 2022
John replied to Aman Verma's discussion Best Skin Doctor | Dr. Kandhari’s Skin and Dental Clinic
"Common Warts, also known as Verruca Vulgaris, is caused by non-malignant strains of human papillomavirus (HPV). They are typically benign lesions that rarely have malignant transformation. On the skin, they appear as rough, painless papules…"
Jun 23, 2022
John posted a discussion

Radiation-induced Esophagitis Market Insights, Epidemiology, and Market Forecast

This section focuses on the rate of uptake of the potential Radiation-induced Esophagitis drugs recently launched in the Radiation-induced Esophagitis market or expected to get launched in the market during the study period 2019-2032. The analysis covers Radiation-induced Esophagitis…See More
Jun 22, 2022
John posted a discussion

Radial Artery Compression Devices Market Report 2032

"DelveInsight’s Radial Artery Compression Devices Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Radial Artery Compression Devices and the historical and forecasted Radial Artery Compression Devices market trends, globally,…See More
Jun 21, 2022
John posted a discussion

Percutaneous Arterial Closure Device Market Insights, Competitive Landscape, and Market Forecast

DelveInsight’s ‘Percutaneous Arterial Closure Device Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Percutaneous Arterial Closure Device and the historical and forecasted Percutaneous Arterial Closure Device market trends,…See More
Jun 20, 2022
John posted discussions
Jun 17, 2022
John posted discussions
Jun 16, 2022
John posted discussions
Jun 14, 2022
John posted a discussion

Langerhans Cell Histiocytosis Market Share, Size, Insights, and Forecast Report

DelveInsight's "Langerhans Cell Histiocytosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Langerhans Cell Histiocytosis, historical and forecasted epidemiology as well as the Langerhans Cell Histiocytosis market trends in the United…See More
Jun 13, 2022
John posted a discussion

Kawasaki Disease Market Share, Size, Insights, and Forecast 2032 by DelveInsight

DelveInsight's Kawasaki Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Kawasaki Disease, historical and forecasted epidemiology as well as the…See More
Jun 10, 2022

Comment Wall

  • No comments yet!

You need to be a member of Personal Growth Systems to add comments!

Join Personal Growth Systems

 
 
 

Welcome

Welcome to the PERSONAL GROWTH SYSTEMS Information network.

Here you will be able to keep up with the latest concepts in unlocking human potential,

Philosophical, and cultural discussions are also welcome.

Please try to keep this a positive forum that focuses on solutions and positive action  No spam please.

If you have any questions, comments or discussions, please post them.

The best place to find me is on facebook or twitter if I'm not here.

Feel free to comment and make friends within the community.

You may envite as many people as you want to join our network. Have fun!

 

This page is best viewed in safari or firefox.

(add your location to the map)

 

 

Who We Are

Personal Growth Systems is a free information forum that focuses specifically on self improvement in every form.

The tools available on this site will allow members to coach and support each other in virtually any aspect of self improvement.

Please use the blog and forum pages to start a discussion so you can get started.

Get a Coach

Hiring a coach or trainer is a great way to take your self improvement goals to the next level.

© 2024   Created by David W. Rhay.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Tweet Tweets by @rhaydavid